Development of a framework for developmental immunotoxicity (DIT) testing

Immunotoxicology and Immunopharmacology, Third Edition

Volumn , Issue , 2006, Pages 347-362

  Holsapple, Michael P ^a   Van Der Laan, Jan Willem ^b   Van Loveren, Henk ^c  

^a International Life Sciences Institute   (United States)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992825730     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (47)

1. Holsapple, M.P., et al., Symposium summary: Children’s Health Risk - What’s so special about the developing immune system? Toxicol. Appl. Pharmac., 199, 61, 2004.
2. Eaton, D.L. and Klaassen, C.D. Principles of toxicology. In: Toxicology: The Basic Science of Poisons, eds. C.D. Klaassen, M.O. Amdur, and J.D. Doull. McGraw-Hill, New York, 1996, 13.
3. Luster, M.I., et al., Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program’s guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol., 10, 2, 1988.
4. Luster, M.I., et al., Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol., 18, 200, 1992.
5. Luster, M.I., et al., Risk assessment in immunotoxicology. II. Relationship between immune function and host resistance tests. Fundam. Appl. Toxicol., 21, 71, 1993.
6. van Loveren, H. and Vos, J.G. Immunotoxicological considera tions: A practical approach of immunotoxicity testing in the rat. In: Advances in Applied Toxicology, eds. A.D. Dayan and A.J. Paine. Taylor and Francis Ltd, London, 1989, 143.
7. van Loveren, H. and Vos, J.G. Testing immunotoxicity of chemicals as a guide for testing approaches for pharmaceuticals. Drug Information Journal, 30 (1), 275, 1996.
8. Koeter, H. International harmonization of immunotoxicity testing. Human & Experimental Toxicology, 14(1), 151-154, 1995.
9. U.S. Environmental Protection Agency. OPPTS 870-7800, Immunotoxicity, Health Effects Test Guidelines. EPA 712-C98-351, 1999.
10. EMEA/CPMP. Note for Guidance on Repeated Dose Toxicity CPMP/SWP/1042/99, http://www.emea.eu.int, 2000.
11. U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Guidance for industry. Immunotoxicology evaluation of investigational new drugs, 2002.
12. International Conference on Harmonisation. ICH-S8, Immunotoxicity Studies for Human Pharmaceuticals, 2005.
13. Barnett, J.B. Developmental Immunotoxicology. In: Experimental Immunotoxicology, eds. R.J. Smialowicz and M.P. Holsapple. CRC Press, Boca Raton, FL, 1996, 47.
14. van Loveren, H. Vos, J.G., Putman, E. and Piersma, A. Immunotoxicological consequences of perinatal chemical exposures: a plea for inclusion of immune parameters in reproduction studies. Toxicology, 185, 185, 2003.
15. Smialowicz, R.J., Brundage, K.M.and Barnett, J.W., Immune system ontogeny and developmental immunotoxicology. In: Immunotoxicology and Immunopharmacology, 3rd ed., eds. R.W. Luebke, I. Kimber and, R.V. House. CRC Press, Boca Raton, FL, 2006, in press.
16. Sandler, J.D. Executive summary: Developmental immunotoxicology and risk assessment. Human Exper. Toxicol., 21(9-10), 469, 2002.
17. Luster, M.I., Dean, J.H. and Germolec, D.R. Consensus workshop on methods to evaluate developmental immunotoxicology. Environ. Health Perspectives, 111, 579, 2003.
18. West, L.J. Defining critical windows in the development of the human immune system. Human Exper. Toxicol, 21(9-10), 499, 2002.
19. Holsapple, M. Developmental immunotoxicology and risk assessment: A workshop summary. Human Exper. Toxicol., 21(9-10), 473, 2002.
20. Holsapple, M.P., West, L.J. and Landreth, K.S. Species comparison of anatomical and functional immune system development. Birth Defects Research, 68, 321, 2003.
21. Landreth, K.S. Critical windows in the development of the rodent immune system. Human Exper. Toxicol., 21(9-10), 493, 2002.
22. Felsburg, P.J. Overview of immune system development in the dog: Comparison with humans. Human Exper. Toxicol., 21(9-10), 487, 2002.
23. Smialowicz, R.J. The rat as a model in developmental immunotoxicology. Human Exper. Toxicol., 21(9-10), 513, 2002.
24. Chapin, R.E. The use of the rat in developmental immunotoxicology studies. Human Exper. Toxicol., 21(9-10), 521, 2002.
25. Holladay, S.D. and Blaylock, B.L. The mouse as a model for developmental immunotoxicology. Human Exper. Toxicol., 21(9-10), 525, 2002.
26. Rothkotter, H.J., Sowa, E., and Pabst, R. The pig as a model of developmental immunology. Human Exper. Toxicol., 21(9-10), 533, 2002.
27. Hendrickx, A.G., Makori, N. and Peterson, R. The nonhuman primate as a model of developmental immunotoxicology. Human Exper. Toxicol., 21(9-10), 537, 2002.
28. Neubert, R.T., Webb, J.R. and Neubert, D. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys. Human Exper. Toxicol., 21(9-10), 543, 2002.
29. Dietert, R.R., et al., Workshop to identify critical windows of exposure for children’s health: immune and respiratory systems work group summary. Environ. Health Perspect., 108(Suppl. 3), 483, 2000.
30. Holsapple, M.P. Developmental immunotoxicity testing: A review. Toxicology, 185, 193, 2003.
31. Ladics, G.S., et al., Characterization of an approach to develop. immunotoxicology assessment in the rat using SRBC as the antigen. Toxicol. Methods, 10, 283, 2000.
32. Kimurs, S., et al., Immunoregulation in the rat: Ontogeny of B cell responses to types 1, 2 and T-dependent antigens. J. Immunol., 134, 2839, 1985.
33. Ladics, G.S., et al., Developmental toxicology evaluations: Issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies. Toxicol. Sci., 88(1), 24-29, 2005.
34. Smialowicz, R.J., et al., The effects of perinatal/juvenile heptachlor exposure on adult immune and reproductive function in rats. Toxicol. Sci., 61, 164, 2001.
35. Chapin, R.E., et al., The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune and reproductive system function. Fundam. Appl. Toxicol., 40, 138, 1997.
36. Carney, E.W., et al., The effects of feed restriction during in utero and postnatal development in rats. Toxicol. Sci., 82, 237, 2004.
37. U.S. Environmental Protection Agency. OPPTS 870-6300, Developmental Neurotoxicity, Health Effects Test Guidelines. EPA 712-C98-239, 1998.
38. Holsapple, M.P., et al., A proposed testing framework for developmental immunotoxicity (DIT). Toxicol. Sci., 83, 18, 2005.
39. Bunn, T.L., Parsons, P.J., Kao, E., and Dietert, R.R. Exposure to lead during critical windows of embryonic development: differential immunotoxic outcome based on stage of exposure and gender. Toxicol. Sci., 64, 57, 2001.
40. U.S. Food and Drug Administration. Guidance for Industry. Nonclinical Safety Evaluation of Pediatric Drug Products. 2003.
41. Bunn, T.L., Ladics, G.S., Holsapple, M.P., and Dietert, R.R. Developmental immunotoxicity assessment in the rat: Age, gender, and strain comparisons after exposure to lead. Toxicol. Methods, 11, 41, 2001.
42. Miller, T.E., et al., Developmental exposure to lead causes persistent immunotoxicity in Fischer 344 rats. Toxicol. Sci., 42, 129, 1998.
43. Gehrs, B.C. and Smialowicz, R.J. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after Perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology, 134, 79, 1999.
44. Cimaz, R., et al., Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. Toxicology Letters, 149, 155, 2004.
45. EMEA Note for Guidance on Preclinical Pharmacological-Toxicological testing of Vaccines. CPMP/SWP/465/95, 1997.
46. WHO Guideline on nonclinical evaluation of vaccines. http://www.who.int/biologicals/publications/nonclinical_evaluation_vaccines_nov_2003.pdf, 2003.
47. Burns-Naas, L.A., Meade, B.J. and Munson, A.E. Toxic response of the immune system. In: Toxicology: The Basic Science of Poisons, ed. C.D. Klaassen, M.O. Amdur, and J.D. Doull. McGraw-Hill, New York, 2001, 419.